The rise of GLP-1 drugs is a reminder that we must move beyond the simple equation of thinness as health and value. These drugs are not the answer to the deep-rooted cultural problem of fatphobia ...

GLP-1RA users had a 37% lower risk of developing dementia compared to those on other antidiabetic drugs. Stroke risk reduced ...